Literature DB >> 25582743

Validation of hepatectomy for elderly patients with hepatocellular carcinoma.

Norihiro Kishida1, Taizo Hibi, Osamu Itano, Koji Okabayashi, Masahiro Shinoda, Minoru Kitago, Yuta Abe, Hiroshi Yagi, Yuko Kitagawa.   

Abstract

BACKGROUND: The safety and feasibility of hepatectomy for hepatocellular carcinoma (HCC) in the elderly population have not been defined to date.
METHODS: A single-center, retrospective cohort study was conducted with 104 patients who underwent hepatectomy for HCC from 2005 to 2010. The patients were divided into two groups, the elderly group (age, ≥75 years; n = 22) and the nonelderly group (age, <75 years; n = 82), for comparison of short- and long-term outcomes.
RESULTS: More patients were categorized as preoperative Eastern Cooperative Oncology Group (ECOG) performance status 1 in the elderly group (32 %) than in the nonelderly group (6 %) (P = 0.003). Complications with a Clavien-Dindo classification of grade 3a or higher were more frequently observed in the elderly group (41 %) than in the nonelderly group (17 %) (P = 0.006). Multivariate logistic regression showed ECOG performance status 1 as the only independent predictor of complications classified as Clavien-Dindo grade 3a or higher. The in-hospital mortality rates were similar between the two groups (P = 0.20). During a median follow-up period of 47 months, the unadjusted 5-year recurrence-free survival rates were similar in the elderly (25 %) and nonelderly (33 %) groups (P = 0.80). Multiple tumors and high alpha-fetoprotein levels emerged as independent negative indicators of recurrence-free survival using multivariate Cox analyses. The adjusted risk for recurrence was not elevated in the elderly group (hazard ratio [HR], 0.92; 95 % confidence interval [CI] 0.50-1.68; P = 0.78).
CONCLUSIONS: Despite the more frequent occurrence of complications with a Clavien-Dindo grade of 3a or higher among the elderly patients undergoing hepatectomy for HCC, their mortality and recurrence rates were comparable with those of the nonelderly patients. Therefore, age alone is not a determinant of surgical candidacy for HCC.

Entities:  

Mesh:

Year:  2015        PMID: 25582743     DOI: 10.1245/s10434-014-4350-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  12 in total

1.  Effect of Age (over 75 Years) on Postoperative Complications and Survival in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma.

Authors:  Roberto Santambrogio; Matteo Barabino; Giovanna Scifo; Mara Costa; Marco Giovenzana; Enrico Opocher
Journal:  J Gastrointest Surg       Date:  2017-01-12       Impact factor: 3.452

2.  Evaluation of the ACS NSQIP Surgical Risk Calculator in Elderly Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.

Authors:  Kota Sahara; Anghela Z Paredes; Katiuscha Merath; Diamantis I Tsilimigras; Fabio Bagante; Francesca Ratti; Hugo P Marques; Olivier Soubrane; Eliza W Beal; Vincent Lam; George A Poultsides; Irinel Popescu; Sorin Alexandrescu; Guillaume Martel; Workneh Aklile; Alfredo Guglielmi; Tom Hugh; Luca Aldrighetti; Itaru Endo; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2019-04-01       Impact factor: 3.452

Review 3.  A Review of Hepatocellular Carcinoma in Elderly Patients Focused on Management and Outcomes.

Authors:  Eunae Cho; Hyun A Cho; Chung Hwan Jun; Hee Joon Kim; Sung Bum Cho; Sung Kyu Choi
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

Review 4.  Hepatocellular carcinoma in the elderly: Meta-analysis and systematic literature review.

Authors:  Annie K Hung; Jennifer Guy
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

5.  Permanent Loss of Preoperative Independence in Elderly Patients Undergoing Hepatectomy: Key Factor in the Informed Consent Process.

Authors:  Travis A Shutt; Prejesh Philips; Charles R Scoggins; Kelly M McMasters; Robert C G Martin
Journal:  J Gastrointest Surg       Date:  2016-01-25       Impact factor: 3.452

6.  Revisiting Partial Hepatectomy of Large Hepatocellular Carcinoma in Older Patients.

Authors:  Guoyong Chen; Jiabin Zhang; Jianjun Sun; Sidong Wei; Jianbin Chen; Hui Ren; Shaotang Zhou
Journal:  Sci Rep       Date:  2018-09-28       Impact factor: 4.379

7.  Radiofrequency ablation versus surgical resection in elderly patients with early-stage hepatocellular carcinoma in the era of organ shortage.

Authors:  Bin Yu; Youming Ding; Xiaofeng Liao; Changhua Wang; Bin Wang; Xiaoyan Chen
Journal:  Saudi J Gastroenterol       Date:  2018 Nov-Dec       Impact factor: 2.485

8.  New landscapes and horizons in hepatocellular carcinoma therapy.

Authors:  Melchiorre Cervello; Maria R Emma; Giuseppa Augello; Antonella Cusimano; Lydia Giannitrapani; Maurizio Soresi; Shaw M Akula; Stephen L Abrams; Linda S Steelman; Alessandro Gulino; Beatrice Belmonte; Giuseppe Montalto; James A McCubrey
Journal:  Aging (Albany NY)       Date:  2020-02-04       Impact factor: 5.682

9.  Efficacy of the association liver partition and portal vein ligation for staged hepatectomy for the treatment of solitary huge hepatocellular carcinoma: a retrospective single-center study.

Authors:  Zhenfeng Deng; Zongrui Jin; Yonghui Qin; Mingqi Wei; Jilong Wang; Tingting Lu; Ling Zhang; Jingjing Zeng; Li Bao; Ya Guo; Minhao Peng; Banghao Xu; Zhang Wen
Journal:  World J Surg Oncol       Date:  2021-03-30       Impact factor: 2.754

10.  Oncologic outcomes after radical surgery for periampullary cancer in octogenarians.

Authors:  Sung Hyun Kim; Jae Uk Chong; Jin Hong Lim; Moon Jae Chung; Jeong Youp Park; Seung Min Bang; Seung Woo Park; Ho Kyung Hwang; Chang Moo Kang; Woo Jung Lee; Kyung Sik Kim
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2018-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.